IRIS Accounts Production v26.3.0.614 04990972 Board of Directors Board of Directors 1.4.25 31.3.26 31.3.26 0 0 false true false false false true false Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh049909722025-03-31049909722026-03-31049909722025-04-012026-03-31049909722024-03-31049909722024-04-012025-03-31049909722025-03-3104990972ns15:EnglandWales2025-04-012026-03-3104990972ns14:PoundSterling2025-04-012026-03-3104990972ns10:Director12025-04-012026-03-3104990972ns10:Director22025-04-012026-03-3104990972ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3104990972ns10:SmallEntities2025-04-012026-03-3104990972ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3104990972ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3104990972ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3104990972ns10:FullAccounts2025-04-012026-03-310499097212025-04-012026-03-3104990972ns10:OrdinaryShareClass22025-04-012026-03-3104990972ns10:CompanySecretary12025-04-012026-03-3104990972ns10:RegisteredOffice2025-04-012026-03-3104990972ns5:CurrentFinancialInstruments2026-03-3104990972ns5:CurrentFinancialInstruments2025-03-3104990972ns5:ShareCapital2026-03-3104990972ns5:ShareCapital2025-03-3104990972ns5:SharePremium2026-03-3104990972ns5:SharePremium2025-03-3104990972ns5:RetainedEarningsAccumulatedLosses2026-03-3104990972ns5:RetainedEarningsAccumulatedLosses2025-03-3104990972ns5:ComputerEquipment2025-03-3104990972ns5:ComputerEquipment2025-04-012026-03-3104990972ns5:ComputerEquipment2026-03-3104990972ns5:ComputerEquipment2025-03-3104990972ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3104990972ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3104990972ns10:OrdinaryShareClass22026-03-3104990972ns5:RetainedEarningsAccumulatedLosses2025-03-3104990972ns5:SharePremium2025-03-3104990972ns5:RetainedEarningsAccumulatedLosses2025-04-012026-03-3104990972ns10:Director112025-03-3104990972ns10:Director112024-03-3104990972ns10:Director112025-04-012026-03-3104990972ns10:Director112024-04-012025-03-3104990972ns10:Director112026-03-3104990972ns10:Director112025-03-31
REGISTERED NUMBER: 04990972 (England and Wales)















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

FOR

MEDIPIN LIMITED

MEDIPIN LIMITED (REGISTERED NUMBER: 04990972)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


MEDIPIN LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2026







DIRECTORS: B L Jacobs
H C Jacobs





SECRETARY: H C Jacobs





REGISTERED OFFICE: 24 Chiltern Avenue
Bushey
Hertfordshire
WD23 4QB





REGISTERED NUMBER: 04990972 (England and Wales)





ACCOUNTANTS: mgr Paris Limited
Chartered Accountants
55 Loudoun Road
St John's Wood
London
NW8 0DL

MEDIPIN LIMITED (REGISTERED NUMBER: 04990972)

STATEMENT OF FINANCIAL POSITION
31 MARCH 2026

31.3.26 31.3.25
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 1,735 2,356
Tangible assets 5 - 2
1,735 2,358

CURRENT ASSETS
Stocks 9,248 5,400
Debtors 6 6,838 6,525
Cash at bank and in hand 3,368 8,472
19,454 20,397
CREDITORS
Amounts falling due within one year 7 13,248 11,994
NET CURRENT ASSETS 6,206 8,403
TOTAL ASSETS LESS CURRENT LIABILITIES 7,941 10,761

CAPITAL AND RESERVES
Called up share capital 8 1,000 1,000
Share premium account 9 24,903 24,903
Retained earnings 9 (17,962 ) (15,142 )
SHAREHOLDERS' FUNDS 7,941 10,761

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MEDIPIN LIMITED (REGISTERED NUMBER: 04990972)

STATEMENT OF FINANCIAL POSITION - continued
31 MARCH 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 October 2026 and were signed on its behalf by:




B L Jacobs - Director



H C Jacobs - Director


MEDIPIN LIMITED (REGISTERED NUMBER: 04990972)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026


1. STATUTORY INFORMATION

Medipin Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Website costs are being amortised evenly over their estimated useful life of twenty years.

Trademarks are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Computer equipment - 33.33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Going concern
The accounts have been prepared under a going concern basis. This is deemed appropriate due to the ongoing support of the directors.

Basic financial assets, which include trade and other debtors and cash and bank balances, are initially measured at transaction price including transaction and where material are subsequently measured at amortise cost using the effective interest method, less any impairment

MEDIPIN LIMITED (REGISTERED NUMBER: 04990972)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026


2. ACCOUNTING POLICIES - continued

Impairment of financial assets
Financial assets, other than those held at fair value are assessed for indicators or impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occured after the initial recognition of the financial asset, the estimated future cash flows have been affected. The impairment loss is recognised in the Statement of Total Comprehensive Income.

Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire, or when it transfer the financial asset and substantially all the risks and rewards of ownership to another entity.

Basic financial liabilities
Basic financial liabilities, including trade and other payables and loans from company undertakings that are classified as debt are initially measured at transaction price unless the arrangement constitute a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at the market rate of interest.

Cash and cash equivalent
Cash and cash equivalent include cash in hand, deposits held at call with banks, other short term liquid investments, with original maturities of three moths or less.

Debtors and creditors receivable / payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2025 - NIL).

4. INTANGIBLE FIXED ASSETS
Website
costs Trademarks Totals
£    £    £   
COST
At 1 April 2025
and 31 March 2026 8,237 2,097 10,334
AMORTISATION
At 1 April 2025 7,187 791 7,978
Amortisation for year 411 210 621
At 31 March 2026 7,598 1,001 8,599
NET BOOK VALUE
At 31 March 2026 639 1,096 1,735
At 31 March 2025 1,050 1,306 2,356

MEDIPIN LIMITED (REGISTERED NUMBER: 04990972)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026


5. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 April 2025
and 31 March 2026 1,656
DEPRECIATION
At 1 April 2025 1,654
Charge for year 2
At 31 March 2026 1,656
NET BOOK VALUE
At 31 March 2026 -
At 31 March 2025 2

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.26 31.3.25
£    £   
Other debtors 6,838 6,525

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.26 31.3.25
£    £   
Trade creditors 1,536 1,067
Taxation and social security 236 93
Other creditors 11,476 10,834
13,248 11,994

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.26 31.3.25
value: £    £   
100,000 Ordinary £0.01 1,000 1,000

MEDIPIN LIMITED (REGISTERED NUMBER: 04990972)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026


9. RESERVES
Share
Retained premium
earnings account Totals
£    £    £   

At 1 April 2025 (15,142 ) 24,903 9,761
Deficit for the year (2,820 ) (2,820 )
At 31 March 2026 (17,962 ) 24,903 6,941

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2026 and 31 March 2025:

31.3.26 31.3.25
£    £   
B L Jacobs
Balance outstanding at start of year (9,026 ) (12,213 )
Amounts advanced 3,500 3,209
Amounts repaid - (22 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (5,526 ) (9,026 )